Camber Pharma Launches Generic Protonix®
Piscataway, NJ, January 22, 2015– Camber Pharmaceuticals announces that it has launched Pantoprazole Sodium Delayed-Release Tablets USP. The drug is the generic version of Protonix® tablets. Pantoprazole is used to treat gastro esophageal reflux disease, (GERD) and damage to the esophagus.
Pantoprazole is available from Camber in 20 and 40mg’s and comes in 90 count bottles.
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected].
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection